The problem of gastric atony

Clinical Techniques in Small Animal Practice

Volumn 19, Issue 1, 2004, Pages 43-48

  Woosley, Kristen P ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISAPRIDE; CLARITHROMYCIN; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; FAMOTIDINE; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; ITRACONAZOLE; KETOCONAZOLE; METOCLOPRAMIDE; NALOXONE; NIZATIDINE; OPIATE RECEPTOR; PROKINETIC AGENT; PUCALOPRIDE; RANITIDINE; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; TEGASEROD; GASTROINTESTINAL AGENT;

ASPIRATION PNEUMONIA; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CRITICAL ILLNESS; DIGESTIVE SYSTEM FUNCTION DISORDER; ELECTRIC ACTIVITY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; IMMUNE FUNCTION TEST; INTESTINE INNERVATION; MORBIDITY; MORTALITY; NEUROMUSCULAR FUNCTION; NONHUMAN; PHYSIOLOGY; REVIEW; SEPSIS; STOMACH; STOMACH EMPTYING; STOMACH PARESIS; ANIMAL; ANIMAL DISEASE; CAT; DOG; ENTERIC FEEDING; INTENSIVE CARE; INTESTINE ABSORPTION; METHODOLOGY; PATHOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIAL TRANSLOCATION; CATS; CRITICAL CARE; DOGS; ENTERAL NUTRITION; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROPARESIS; INTESTINAL ABSORPTION;

EID: 1642445425     PISSN: 10962867     EISSN: None     Source Type: Journal    
DOI: 10.1053/S1096-2867(03)00083-5     Document Type: Article

References (44)

1. Guilford G. Motility disorders of the bowel. Guilford W.G., Center S.A., Strombeck D.R.,, et al. Strombeck's Small Animal Gastroenterology. ed. 3 :1996;532-538 Saunders, Philadelphia
2. Heyland D.K., Tougas G., King D., et al. Impaired gastric emptying in mechanically ventilated, critically ill patients. Intens Care Med. 222:1996;1339-1344
3. Zaloga G.P. Early enteral nutritional support improves outcome. Hypothesis or fact? Crit Care Med. 27:1999;259-261
4. Booth C.M., Heyland D.K., Paterson W.G. Gastrointestinal promotility drugs in the critical care setting a systematic review of the evidence. Crit Care Med. 30:2002;1429-1435
5. Reignier J., Bensaid S., Perrin-Gachadoat D. Erythromycin and early enteral nutrition in mechanically ventilated patients. Crit Care Med. 30:2002;1237-1241
6. Zaloga G.P., Marik P. Promotility agents in the intensive care unit. Crit Care Med. 28:2000;2657-2659
7. Guyton A.C., Hall J.E. General principles of gastrointestinal functions. Guyton A.C., Hall J.E. Textbook of Medical Physiology. ed. 9 :1996;793-798 Saunders, Philadelphia
8. Malagelada J.R., Azpiroz F., Mearin F. Gastroduodenal motor function in health and disease. Sleisenger M.H., Fordtran J.S. Gastrointestinal Disease. ed. 5 :1993;486-489 Saunders, Philadelphia
9. Hall J.A., Washabau R.J. Gastrointestinal prokinetic therapy motilin-like drugs. Compend Cont Educ Pract Vet. 19:1997;281
10. Hall J.A., Washabau R.J. Diagnosis and treatment of gastric motility disorders. Vet Clinics of N Am. 29:1999;384-395
11. Hall J.A., Twedt D.C. Gastric motility disorders in dogs. Part II. Disorders of gastric motility. Compend Cont Educ Pract Vet. 12:1990;1373-1387
12. Washabau R.J., Hall J.A. Diagnosis and management of gastrointestinal motility disorders in dogs and cats. Compend Cont Educ Pract Vet. 19:1997;6727
13. Marks S. Enteral feeding devices what's old, what's new. Proceedings of the WSAVA World Congress. 2001;342-348 WSAVA, Vancouver, Canada
14. Neumann D.A., DeLegge M.H. Gastric vs. small-bowel feeding in the intensive care unit a prospective comparison of efficacy. Crit Care Med. 30:2002;1436-1438
15. Miskovitz P. Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit. Crit Care Med. 30:2002;1386-1387
16. Swann H.M., Sweet D.C., Michel K. Complications associated with the use of jejunostomy tubes in dogs and cats 40 cases (1989-1994). JAVMA. 210:1997;1764-1767
17. Hall JA: Washabau RJ: Gastrointestinal prokinetic therapy: dopaminergic antagonist drugs. Compend Cont Educ Pract Vet 19:214
18. Barone J.A. Domperidone a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother. 33:1999;429-440
19. Gullikson G.W., Loeffler R.F., Virina M.A. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. J Pharmacol Exp Ther. 258:1991;103-109
20. Soykan I., Sarosiek I., McCallum R.W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 92:1997;976-980
21. Prins N.H., Akkermans L.M., Lefebvre R.A., et al. Characterization of the receptors involved in the 5-HT induced excitation of canine antral longitudinal muscle. Br J Pharmacol. 134:2001;1351-1359
22. Prins N.H., Van Der Grijn A., Lefebvre R.A., et al. 5-HT4 receptors mediating enhancement of contractility in canine stomach an in vitro and in vivo study. Br J Pharmacol. 132:2001;1941-1947
23. Hannon J., Hoyer D. Serotonin receptors and systems endless diversity? Acta Biol Szeged. 46:2002;1-12
24. Tanaka T., Mizumoto A., Suzuki H., et al. Effects of EM574 and cisapride in gastric contractile activity on gastric contractile and emptying in normal and drug-induced gastroparesis in dogs. J Pharmacol Exp Ther. 287:1998;712-719
25. Edelbroek M., Schurkes J., DeRidder W., et al. Effect of cisapride on myoelectric and motor responses of antropyloroduodenal region during intraduodenal lipid and antral tachygastria in conscious dogs. Dig Dis Sci. 40:1995;901-911
26. Briejer M.J., Prins N.H., Schuurkes J.A. Effects of enterokinetic prucalopride (RO93877) on colonic motility in fasted dogs. Neurogastroenterology. 13:2001;465-472
27. Boeckxstaens G.E., Pelkmans P.A., Rampart M., et al. Pharmacologic characterization of 5-HT receptors in the canine terminal ileum and ileocolonic junction. J Pharmacol Exp Ther. 254:1990;652-658
28. Taniyama K., Nakayama S., Takeda K., et al. Cisapride stimulates motility of the intestine via 5-Hydroxytryptamine receptors. J Pharmacol Exp Ther. 258:1991;1098-11043
29. Gullickson G.W., Virina M.A., Loeffler R.F., et al. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-HT4 mechanism. J Pharmacol Exp Ther. 264:1993;240-248
30. Washabau R.J., Hall J.A. Gastrointestinal prokinetic therapy serotonergic drugs. Compend Cont Educ Pract Vet. 19:1997;473
31. Washabau R.J. GI motility disorders in the critical patient. Proc. IVECCS. 2002;215-219
32. Rondeau M., Meltzer K., Washabau R. Prucalopride a 5HT-4 agonist, stimulates canine and feline colonic smooth muscle contraction. JVIM. 16:2002;327. (abstr)
33. Hall J.A., Washabau R.J. Gastrointestinal prokinetic therapy acetylcholinesterase inhibitors. Compend Cont Educ Pract Vet. 19:1997;615
34. Carlson R.G., Hocking M.P., Sninsky C.A., et al. Erythromycin acts through a cholinergic pathway to improve canine-delayed gastric emptying following vagotomy and Roux en Y antrectomy. J Surg Res. 50:1991;494-498
35. Sato F., Marui S., Inatomi N., et al. EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs. Eur J Pharmacol. 395:2000;165-172
36. Dive A., Miesse C., Galanti L., et al. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients. Crit Care Med. 23:1995;1356-1362
37. Chapman M.J., Fraseer R.J., Kluger M.T., et al. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med. 28:2000;2334-2337
38. Culpepper J.A., Inturissi C.E., Portenoy R.K., et al. Treatment of opioid-induced constipation with oral naloxone a pilot study. Clinical Pharmacol Ther. 52:1992;90-95
39. Meissner W., Schmidt U., Hartmann M., et al. Oral naloxone reverses opioid-associated constipation. Pain. 84:2000;105-109
40. Meissner W., Dohrn B., Reinhart K. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia. Crit Care Med. 31:2003;776-780
41. Taguchi A., Sharma N., Saleem R., et al. Selective postoperative inhibition of gastrointestinal opioid receptors. NEJM. 345:2001;935-940
42. Sykes N.P. Oral naloxone in opioid-associated constipation. The Lancet. 337:1991;1475. (abstr)
43. Spapen H.D., Duinslaeger L., Diltoer M., et al. Gastric emptying in critically ill patients is accelerated by adding cisapride to a standard enteral feeding protocol. Crit Care Med. 23:1995;481-485
44. Goldhill D.R., Toner C.C., Tarling M.M., et al. Double-blind, randomized study of the effect of cisapride on gastric emptying in critically ill patients. Crit Care Med. 25:1997;447-451